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Shigella spp. are Gram-negative bacterial pathogens that infect human colonic epithelia
and cause bacterial dysentery. These bacteria express multiple copies of a syringe-like
protein complex, the Type Three Secretion apparatus (T3SA), which is instrumental in
the etiology of the disease. The T3SA triggers the plasma membrane (PM) engulfment
of the bacteria by host cells during the initial entry process. It then enables bacteria
to escape the resulting phagocytic-like vacuole. Freed bacteria form actin comets to
move in the cytoplasm, which provokes bacterial collision with the inner leaflet of the
PM. This phenomenon culminates in T3SA-dependent secondary uptake and vacuolar
rupture in neighboring cells in a process akin to what is observed during entry and
named cell-to-cell spread. The activity of the T3SA of Shigella flexneri was recently
demonstrated to display an on/off regulation during the infection. While the T3SA is active
when bacteria are in contact with PM-derived compartments, it switches to an inactive
state when bacteria are released within the cytosol. These observations indicate that
effector proteins transiting through the T3SA are therefore translocated in a highly time
and space constrained fashion, likely impacting on their cellular distribution. Herein, we
present what is currently known about the composition, the assembly and the regulation
of the T3SA activity and discuss the consequences of the on/off regulation of T3SA
on Shigella effector properties and functions during the infection. Specific examples
that will be developed include the role of effectors IcsB and VirA in the escape from
LC3/ATG8-positive vacuoles formed during cell-to-cell spread and of IpaJ protease
activity against N-miristoylated proteins. The conservation of a similar regulation of T3SA
activity in other pathogens such as Salmonella or Enteropathogenic Escherichia coli will
also be briefly discussed.
Keywords: Shigella, type three secretion apparatus, type three secretion system, effectors, enteropathogens,
host-pathogen interactions, signal transduction
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INTRODUCTION
Shigella spp. (e.g., S. flexneri, S. sonnei, S. dyssenteriae, and
S. boydii) are gram negative enteropathogen bacteria that are
closely related to commensal Escherichia coli. As such, they
are often considered to be E. coli. pathovars. Homo sapiens
are the only known natural hosts of Shigella spp. By invading
the colonic mucosa, Shigella spp. cause dysentery that is
characterized by bloody and mucous rich diarrhea accompanied
by abdominal cramps. There are about 200 million infection
cases annually and ∼1.1 million deaths, among which the
majority are children under 5 years (Kotloff et al., 1999).
Associated to poor sanitation and water quality control (Kotloff
et al., 1999; Phalipon et al., 2008; Johansson et al., 2009), the
prevalence of the disease is highly correlated with economic
wealth. In addition, the etiology of the disease differs between
low- and high-income countries, where S. flexneri and S.
sonnei prevail, respectively. Potential reasons for this remarkable
phenomenon are discussed in detail elsewhere (Thompson et al.,
2015).
Shigella spp. pathogenicity essentially depends on a large
virulence plasmid of∼200 kb that is also found in enteroinvasive
E. coli (EIEC). This virulence plasmid (Buchrieser et al., 2000;
Venkatesan et al., 2001; Zhang et al., 2003; Jiang et al., 2005),
and the chromosomes (Lukjancenko et al., 2010; Onodera
et al., 2012) of many Shigella spp. have now been sequenced.
Still, the majority of what we know concerning the infectious
cycle of Shigella spp. and the molecular determinants of their
pathogenicity comes from studies on S. flexneri, namely strains
M90T (serotype 5a), 2457T (serotype 2a), and YSH6000 (serotype
2a) either in in vitro culture of immortalized intestinal cells, or
from the infection of various animal hosts, including primate,
rabbit, guinea pig, or mouse (Sansonetti et al., 1983; Sansonetti
and Arondel, 1989; Martino et al., 2005; Shim et al., 2007;
Arena et al., 2015). While none of these experimental systems
constitute a natural Shigella host, they have nevertheless provided
many insights about the inflammatory response component of
shigellosis. This is particularly true of the rabbit ileal loop model
(Sansonetti et al., 1983; Schnupf and Sansonetti, 2012; Puhar
et al., 2013).
The infectious cycle of Shigella spp. consists in several
consecutive steps. Upon their adhesion to host cells, Shigella spp.
use genes expressed from their virulence plasmid to trigger their
uptake by otherwise non-phagocytic epithelial cells, access their
host cell cytoplasm and then, eventually spread to neighboring
cells (reviewed in Valencia-Gallardo et al., 2015). The virulence
plasmid also allows the bacteria to survive inside and kill
macrophages (Zychlinsky et al., 1992; Fernandez-Prada et al.,
2000; Suzuki et al., 2014), and perturb the function of T
and B cells (Konradt et al., 2011; Salgado-Pabón et al., 2013;
Nothelfer et al., 2014). Protein products of many genes harbored
on the virulence plasmid are necessary for the assembly of
a nanomolecular machine named the Type Three Secretion
Apparatus (T3SA) (Burkinshaw and Strynadka, 2014). Also
known as injectisome, this T3SA plays an essential role in most
of Shigella invasion steps. The T3SA spans the bacterial inner
and outer membranes adopting roughly the shape and function
of a syringe. T3SA have a narrow conduit in their center that
permits the secretion of proteins. In the initial stage of T3SA
activation that takes place after initial contacts with the PM,
a first class of protein called translocators are secreted. The
translocators assemble to form a pore also called translocon
across the host membrane. A second group of proteins called
effectors then transit through the T3SA and ultimately through
the pore to be delivered in the host cytoplasm. Simultaneously
the host PM engulf the bacteria through a process requiring
actin microfilaments remodeling, similarly to what is seen is
regular phagocytosis (reviewed in Ménard et al., 1996; Carayol
and Tran Van Nhieu, 2013; Valencia-Gallardo et al., 2015). The
bacterial uptake is completed when bacteria are found in closed
vacuoles. The T3SA is also necessary for subsequent rupture of
these vacuoles (Blocker et al., 1999; Page et al., 1999; Schuch
et al., 1999; Paz et al., 2010). Once in the cytoplasm Shigella
spp. use the outer membrane protein IcsA (also known as
VirG) to form actin comet tails that enable cytoplasm movement
and ultimately, cell-to-cell spreading (Bernardini et al., 1989).
The collision of a motile bacterium with the inner leaflet of
the PM leads to the formation of a protrusion, which is a
double membrane finger-like projection of the PM of the initially
infected cells into a neighboring cell. Protrusions resolved into
secondary vacuole (Campbell-Valois et al., 2014b; Dragoi and
Agaisse, 2014; Kuehl et al., 2015); secretion of translocators
and effectors are known to be essential, as well, for the lysis
of secondary vacuoles through a process hypothesized to be
essentially similar to entry (Page et al., 1999; Schuch et al.,
1999). The ensuing release of bacteria into the cytoplasm
of secondary infected cells effectively completes cell-to-cell
spreading events.
As yet, the translocators and effectors arsenal of S. flexneri is
encoded by 32–38 genes (Buchrieser et al., 2000; Ogawa et al.,
2008; Parsot, 2009). While the N-terminal region of most of these
effectors appears required for their targeting to the T3SA, their
level of homology do not allow the identification of any clear
consensus targeting sequence (Ramamurthi and Schneewind,
2003; Ghosh, 2004; Lilic et al., 2006). In addition, the structural
stability of several of these effectors and their efficient targeting to
the T3SA can be dependent on the formation of a complex with
their cognate chaperone protein (reviewed in detail elsewhere
Burkinshaw and Strynadka, 2014). The nine effectors that binds
the chaperone Spa15 were recently shown to harbor a conserved
chaperon binding domain required for efficient secretion and
conserved across many pathogen species (Costa et al., 2012).
However, most of the effectors, whose expression is up regulated
when T3SA are active, do not seem to necessitate any chaperone
(Parsot, 2009).
In this review, we first focus on the current knowledge
concerning the assembly and the structure of the T3SA. We
then describe the evidences indicating that Shigella T3SA activity
oscillates depending on the adhesion of bacteria to the host
PM. In the third part, we discuss the consequences of this
dynamic activity of the T3SA on the properties and functions
of Shigella effectors. Finally, we relay this model to recent data
concerning effector functions and discuss its extension to other
T3SA-bearing pathogens.
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EXPRESSION, ASSEMBLY, AND
STRUCTURE OF SHIGELLA T3SA
The expression of T3SA is controlled at the transcriptional
level. Essential genes for assembly of T3SA are located in
two juxtaposed, but inversely oriented operons, located in
the center of the virulence plasmid: the mxi/spa operon
(approximately 20 kb length and 26 genes) and the ipaABCD
operon (∼10 kb length and 10 genes) (Buchrieser et al., 2000).
Importantly, the transcription of the T3SA is tightly associated
and synchronized to those of the effector proteins. Indeed, at
temperature above >32◦C, inhibition by the nucleoid factor H-
NS is relieved (Maurelli and Sansonetti, 1988; Falconi et al., 1998,
2001), triggering a signaling cascade implicating transcription
activators VirF and VirB that induces the expression of mxi/spa
and ipaABCD operons (Tobe et al., 1991; Kane and Dorman,
2012). The output of this cascade consists in the formation of
an intracellular store of translocators and so-called first wave
effectors with their cognate chaperones (Ménard et al., 1994b),
and the assembly of T3SA (Figure 1). Therefore, bacteria at
permissive temperatures display at their surface inactive T3SA
that can be switched to the active state upon contact with
host cells, allowing almost instantaneous secretion of prestored
translocators and effectors (Enninga et al., 2005).
The inactive T3SA is hierarchically assembled in the
bacterial membranes (reviewed in detail elsewhere Burkinshaw
and Strynadka, 2014) (Figure 1). Proteins MxiG/MxiJ and
MxiD/MxiM, constituting the inner and outer membrane rings
of the basal body of the T3SA, respectively, are assembled first
(Hodgkinson et al., 2009). MxiA, Spa13, and Spa47 and the
sorting platform, which is composed of Spa33, MxiK, and MxiN
(Morita-Ishihara et al., 2006; Lara-Tejero et al., 2011; Hu et al.,
2015), associate with the cytoplasmic face of the inner membrane
ring where they can recognize proteins targeted to the T3SA.
Remarkable high resolution electron microscopy images of the
T3SA of Shigella, recently provided compelling evidence about
the composition and function of the cytoplasmic components of
the T3SA, including the sorting platform (Hu et al., 2015). On
the basis of its Salmonella homolog PrgJ, the rod protein MxiI is
hypothesized to associate with the socket in the upper part of the
inner membrane ring and contribute to regulating secretion of
MxiH (Marlovits et al., 2006), which homopolymerizes to form
the needle of the syringe (Demers et al., 2013). Interaction of
Spa32 with Spa40 is also essential for the formation of needles
(Botteaux et al., 2008, 2010). Spa32, the homolog of YscP in
Yersinia pestis (Journet et al., 2003), acts as a molecular ruler and
is secreted when the needle reaches the correct length (Botteaux
et al., 2008). A small fraction of the total cellular pool of IpaB
and IpaD is then secreted, but remains associated with the needle,
hence forming the tip complex. In the absence of activation
signal, the tip complex is closed and composed of onemolecule of
IpaB and four molecules of IpaD (Veenendaal et al., 2007; Epler
et al., 2012; Cheung et al., 2015). The association of the closed
conformation of the tip complex with the needle is a hallmark
of inactive T3SA. In contrast, T3SA devoid of this normal tip
complex, which are obtained by deletion of the ipaB or ipaD
locus, are constitutively active (Ménard et al., 1993, 1994a). In the
case of the ipaBmutated strain, the open conformation of the tip
FIGURE 1 | Scheme of the type three secretion apparatus of Shigella
flexneri. Basic scheme of Shigella flexneri T3SA at permissive temperatures
(e.g., 37◦C) in the inactive (A) and active states (B). The tip complex is
composed of IpaD (grey circles) and IpaB (white rectangles) adopting a closed
conformation and an open conformation in the inactive and active states,
respectively. Activation of secretion leads to MxiE-IpgC-dependent expression
of second wave effectors. The dashed arrow indicates the route followed by
translocators and effectors during secretion. They travel through a conduit
located at the center of the T3SA that comprises successively the sorting
platform, the inner membrane ring, rod protein (not visible on this scheme), the
outer membrane ring, the needle, and translocon. Numbers in parenthesis in
the right panel indicate the secretion order of translocators, first wave and
second wave effectors. Labelings of bacterial cytoplasmic complex
components are indicated from left to right. IM, inner membrane; OM, outer
membrane; HPM, host plasma membrane.
complex appeared to be formed of five IpaD molecules (Cheung
et al., 2015), but it is likely that total absence of a tip complex
would also lead to deregulated secretion. In the inactive state
of T3SA, the gatekeeper protein MxiC blocks effectors secretion
(Botteaux et al., 2009; Martinez-Argudo and Blocker, 2010). It
does so by associating with the entrance of the inner conduit of
the T3SA, probably through binding with MxiI (Cherradi et al.,
2013). MxiC remains at this position until it is itself secreted, an
event that is probably induced by the depletion of the intracellular
store of translocators occurring in the active state, and that may
involve needle conformational changes (Martinez-Argudo and
Blocker, 2010).
REGULATION OF THE ACTIVITY OF
SHIGELLA T3SA INSIDE INFECTED CELLS
The T3SA is activated upon contacting the host cell, likely upon
binding of the tip complex to cholesterol and/or sphingolipid
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molecules composing the host PM (Lafont et al., 2002; van
der Goot et al., 2004; Veenendaal et al., 2007; Epler et al.,
2009). This activation triggers the secretion of the cytoplasmic
fraction of translocators IpaB and IpaC. IpaB and IpaC insert
into the host PM to form a pore, or translocon, through which
effectors will be transferred into the host cytoplasm (Figure 1)
(Edgren et al., 2012). Thus, a first hallmark of an active T3SA
state is the adoption of an open conformation by the tip
complex or, alternatively, its absence from the needle of active
T3SA. Both situations result in the unsealing of the syringe. A
second hallmark is the cooperation between the T3SA and the
translocon. Importantly, this cooperation is necessary to infect
cells, but dispensable for constitutive in vitro activity, as for
example in the case of ipaB and ipaDmutant strains.
Upon persistent activation of the T3SA, bacteria intracellular
stores of translocators IpaB and IpaC and of the anti-activator
OspD1 become depleted (Figure 1). This putatively allows the
formation of a complex between the translocator chaperone IpgC
and the transcription activator MxiE (Pilonieta and Munson,
2008), which induce the expression of genes harboring a MxiE-
box (Mavris et al., 2002a,b; Le Gall et al., 2007; Bongrand et al.,
2012). Genes possessing a MxiE-box hence constitute a second
wave of effectors that are secreted through the T3SA (Parsot,
2009) (Figure 1).
Transcriptional fusions of MxiE-box containing promoters
with β-galactosidase (LacZ) were constructed and used to
monitor the T3SA activity of bacteria recovered from infected
HeLa epithelial cells (Demers et al., 1998). HeLa cells are not
very permissive for cell-to-cell spreading (Tran Van Nhieu et al.,
2003), but allow the study of events taking place during the
initial uptake and vacuolar rupture. In the absence of secretion
activity, such as when bacteria are grown in broth at 37◦C, the
β-galactosidase activity of MxiE-promoters was nil. In contrast,
when bacteria were put in contact with Hela cells, the β-
galactosidase activity of MxiE-promoters was induced. The β-
galactosidase activity of Shigella recovered from HeLa cells was
higher at 60 than at 150min post-entry. The activity at 150min
had in fact decreased to the background level observed in bacteria
cultivated in absence of host cells. These results provided the first
indication that following entry into epithelial cells, T3SA were
inactivated (Demers et al., 1998).
Use of the green fluorescent protein (GFP) allowed the design
of fluorescent Transcription-based Secretion Activity Reporter
(TSAR) relying on the MxiE-promoter of ipaH7.8. The TSAR
allowed for monitoring the T3SA activity inside infected cells
in close to real-time fashion (Campbell-Valois et al., 2014a,b). It
confirmed the results obtained with the previous β-galactosidase
transcriptional fusion (Demers et al., 1998). Indeed, the secretion
proved inactivated in the host cell cytoplasm 30–60min post-
entry. In addition, because these experiences were performed
in colonic epithelial cell line TC7 (a clone of Caco-2), the
dynamic of the TS3A activity during the spreading of bacteria to
neighboring cells could be observed. Interestingly, a significant
fraction of bacteria that had escaped the entry vacuole were
observed to reactivate their secretion between 60 and 120min
post-entry. Based on several lines of evidence, this phenotype
was attributed to the fraction of motile cytoplasmic bacteria that
had formed protrusions (Figure 2A). For example, non-motile
Shigella obtained by genetic manipulation (e.g., icsA mutant) or
treatment with the actin polymerization inhibitor cytochalasin D,
both resulted in background level of T3SA secretion activity at
240min post-entry. In contrast, using a conditional mutant ipaC
allele that remained trapped in protrusions or in vacuoles that
derived from it, or using the F-actin depolymerizing inhibitor
jasplakinolide, which induced host cell retraction that causes
random collisions between intracellular bacteria and the PM,
we demonstrated that interactions of cytoplasmic bacteria with
the PM compartments formed during cell-to-cell spread was
critical for reactivation of T3SA. These results demonstrate
that interactions of cytoplasmic bacteria with the PM formed
during cell-to-cell spread were critical for reactivation of T3SA.
Fluorescence Recovery After Photobleaching (FRAP) of the
TSAR indicated that the secretion activity was induced when
bacteria were trapped in protrusions and in a lesser measure
in vacuoles, but not in cytoplasmic bacteria (Campbell-Valois
et al., 2014b). This study indicated that intracellular Shigella
undergoes cyclical all-or-none activation of its T3SA depending
on interactions with the PM during entry or cell-to-cell spreading
steps of the infection cycle. In addition, these results also indicate
that endomembrane compartments are likely unable to induce
T3SA activation. Whether this phenomenon stems from the
biochemical composition of the endomembrane compartments
itself, which would fail to activate T3SA due to weaker mutual
interactions, or from the infrequent docking of Shigella on
endomembrane compartments is an open question. It is also
possible that T3SA display low level activity or too transient
activation in the cytoplasm to be detectable with the TSAR
system. Another important question to tackle is the regulatory
mechanism of T3SA activity in infected cells and tissue. How
T3SA can be activated both during entry and cell-to-cell spread
while the bacteria is alternately facing the external face of a
single PM and the internal face of a double PM (Figure 2B)?
Additionally, what are the mechanisms of inactivation of T3SA
in the cytoplasm (Figure 2C)? Concerning the latter question, the
most plausible mechanism is the reconstitution of tip complexes
composed of newly synthesized IpaB and IpaD capable of
plugging T3SA shortly after loss of contacts with the vacuolar
membrane. The alternative hypothesis of a partial or complete
disassembly of T3SA following bacterial release in the cytoplasm
appears less likely, but cannot be completely ruled out yet
(Campbell-Valois et al., 2014b).
A MODEL INTEGRATING THE INFLUENCE
OF THE OSCILLATING T3SA ACTIVITY ON
THE PROPERTIES AND FUNCTIONS OF
EFFECTORS
As delineated above, Shigella infectious cycle can be summed up
as an “invade and evade” strategy, where bacteria first “invade”
cells by triggering their own uptake in epithelial cells (or by not
blocking their uptake by professional phagocytes) and “evade”
the vacuole formed around them during phagocytosis using
membrane-disrupting translocators and effectors. Once bacteria
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FIGURE 2 | Shigella infectious cycle: interaction of T3SA with membrane compartments is key for the regulation of its activity. The “invade and evade”
infectious strategy of S. flexneri can be broken down in two phases: (1) entry, characterized by residence of bacteria in vacuoles derived from the PM (1a,b), which
are ultimately ruptured (1c); (2) cytoplasmic residence, where most replication events occur (2a) and motility through actin comet formation is possible (2b). After
bacteria have reached the cytoplasm, they are in position to iterate this cycle and progressively invade neighboring cells, before evading once again the secondary
vacuole. This process is characterized by the formation of protrusions (3a) and vacuoles (3b) composed of a double membrane derived from the PM in which bacteria
reside until their lysis (3c), and escape in the cytoplasm (2*). It was demonstrated that secreting bacteria (green) were systematically associated with entry and
cell-to-cell spread vacuoles and protrusions derived from the PM, while cytoplasmic bacteria were not actively secreting (gray) (A). Magnification of the inner and outer
leaflet of the PM. Density of cholesterol (yellow rectangles) and overall phospholipids composition (pink vs. blue) is variable in both leaflets. Therefore, bacteria are not
facing the same biochemical cues when they are performing entry vs. cell-to-cell spread. As mentioned in panel (A), bacteria also face four membranes during
cell-to-cell spread instead of two during entry (B). Proposed mechanisms of inactivation of T3SA in intracellular Shigella. Grey circles and white rectangles represent
secreted tip complex proteins, which are incapable of blocking T3SA conduit. H1 and H2 represent alternative hypotheses for inactivation of T3SA in the cytoplasm of
host cells, as described in the text. H1: replenishment of functional tip complex; H2: disassembly of T3SA before vacuole escape and replenishment with inactive
T3SA in the host cytoplasm (C).
have evaded their vacuole, they are in position to iterate this
cycle and progressively invade neighboring cells, before evading
once again the secondary vacuole. The observation that the
T3SA oscillates between its active and inactive states between
two “invade-evade” cycles (Campbell-Valois et al., 2014b) has
likely important consequences on the subcellular distribution of
bacterial effectors during infection. This subcellular distribution
is influenced by three main parameters: the location of secretion,
the regulation of secretion, and the diffusion capacity of the
effector within the host cytoplasm, either passively through
Brownian movement or actively by binding specific host factors
or organelles. The cellular cytoplasm is characterized by a high
concentration of biomolecules or macromolecular crowding,
which considerably impedes the excluded volume of solvent
accessible to diffusing proteins, hence decreasing their diffusion
rate (Zhou et al., 2008). The macromolecular crowding is
heterogeneous and peaks at the vicinity of the host cell PM
(Kühn et al., 2011). In consequence, the protein diffusion rate
in this region is decreased (Kühn et al., 2011). The formation of
protein complexes and the level of cytoskeleton polymerization
participate to the heterogeneity of the macromolecular crowding.
Therefore, any perturbation in the density of the cytoskeleton
network can potentially further restricts protein diffusion.
Interestingly, many pathogens such as Salmonella, E. coli, and
Shigella, increase the density of the actin meshwork in their
vicinity using T3SA effectors. Specifically, Shigella entry and cell-
to-cell spreading is characterized by the formation of actin foci or
actin rich structures around actively secreting bacteria (Carayol
and Tran Van Nhieu, 2013). Specific Shigella effectors involved in
that process will be discussed later.
Hence, if the intrinsic properties of effectors as well as their
capacity to interact with host protein targets obviously play a
determinant role in their function, the site of their secretion is
also crucial (Galán, 2009). Furthermore, the realization that the
T3SA activity is maximal in PM-derived compartments such as
protrusions and bacteria-containing vacuoles strongly suggests
that the effective concentration of effectors upon their secretion
should follow a very steep gradient (Figure 3A). This prediction
was experimentally corroborated by the apparent retention of
translocators and effectors in the vicinity of actively secreting
bacteria (Campbell-Valois et al., 2014b, 2015). This high effective
concentration of effectors should hence potentiate their binding
and enzymatic properties, as long as their host protein targets are
as well localized in this region.
Despite the importance of the initial local concentration
of effectors, experimental observations of their subcellular
distribution have demonstrated that many effectors can
nevertheless eventually diffuse from their secretion site, when
given enough time (Campbell-Valois et al., 2014b, 2015). Again,
the diffusion rate and the final subcellular distribution of
these effectors will depend on the properties of the cytoplasm
of the (infected) cell and the intrinsic properties of effectors
(Figure 3B). Therefore, the local delivery and ensuing diffusion
of effectors may confer them two sets of functions: one in the
vicinity of secreting bacteria (i.e., local functions) and one
upon diffusion across the infected cell (i.e., distant functions)
(Figure 4). The balance between local vs. distant functions for
a given effector would also be modulated by the actual amount
of secreted effector, the relationship between its binding affinity
and/or catalytic activity toward its host targets and its stability
or half-life. Finally, the amount of actively secreting bacteria
within a given infected host cell might also impact on the
concentration and therefore the distribution of effectors across
infected cells. Distant functions might be favored, when the
amount of bacteria and secreted effectors cell rise and/or when
the amount of actively secreting bacteria decreases in infected
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FIGURE 3 | Factors impacting on the concentration and distribution of
effectors inside host cells. Theoretical concentration and distribution of
bacterial effectors in an uninfected cell (left) vs. in infected cells in the case
scenario where all intracellular bacteria (center) or only those in vacuoles are
secreting (right) (A). An actively secreting bacterium located in a vacuole is
represented with its theoretical gradient of effectors. Arrows oriented away and
toward the bacteria represent respectively factors favoring or disfavoring rapid
and homogenous diffusion of effectors inside host cells (B). Secreting bacteria,
green; non-secreting bacteria, gray. Color scale represents concentration of
effectors from 0 (min) to 1 (max) (arbitrary unit).
host cells (Campbell-Valois et al., 2014b). In conclusion, this
local/distant model of effectors function would provide a passive
and nevertheless elegant manner for bacteria to adapt their
activity in regard of the bacterial load within host cells.
RECENT PROGRESSES IN THE ROLE OF
SHIGELLA EFFECTORS DURING
INFECTION: EVIDENCE FOR AND
AGAINST OUR MODEL
Examples of Effector Acting Locally, Near
their Secretion Site
Few studies performed on S. flexneri support the existence of local
function of effectors. A classical example is the local function
of IpaB (in collaboration with IpaC) through its translocon-
forming ability to induce bacterial uptake and vacuole rupture
(Blocker et al., 1999; Page et al., 1999; Schuch et al., 1999; Carayol
and Tran Van Nhieu, 2013), which can be contrasted with
IpaB distant function in inducing pyroptosis of macrophages
once liberated in their cytoplasm (Zychlinsky et al., 1992, 1994).
Other effectors implicated in F-actin manipulation, such as IpaA,
IpgB1, and IpgB2 are also known to act near or around the
actin foci to enable bacterial uptake (Carayol and Tran Van
Nhieu, 2013). Phosphatidylinositol-5-phosphate produced by the
inositol phosphate phosphatase IpgD is enriched around entry
sites (actin foci), suggesting IpgD is acting in the vicinity of its
secretion site (Pendaries et al., 2006). However, the reduction
in the concentration of its substrate phosphatidylinositol-4,5-
biphosphate is rapidly detected in whole cell extract (Niebuhr
et al., 2002), and a range of global to local effects of the enzymatic
activity of IpgD has been reported in the literature (Puhar et al.,
2013; Mellouk et al., 2014), complicating the portrait. When it
comes to events downstream of entry, reports of effectors acting
locally have been scarcer, although a few examples have emerged.
Recently, the fragmentation of the golgi apparatus of infected
epithelial cells was reported independently by two research
groups (Mounier et al., 2012; Burnaevskiy et al., 2013). A
newly identified effector named IpaJ has been implicated in
this phenotype (Burnaevskiy et al., 2013, 2015; Dobbs et al.,
2015). IpaJ does so using its cysteine protease activity to cleave
the N-miristoyl modification of ARF1 and ARF2 (Burnaevskiy
et al., 2013). In a latter study, the same group revealed that
IpaJ demiristoylated a large group of host proteins during
in vitro experiments, but that it was highly specific to Golgi
apparatus-associated ARF/ARL small GTPases when delivered
inside host cells through the T3SA (Burnaevskiy et al., 2015).
Specificity was also mediated in part by the capacity of IpaJ to
recognize the GTP-bound form of golgi associated ARFs. Other
factors impacting on the subcellular localization of IpaJ could be
implicated in the selections of its substrates, as it also recognizes
the GTP-bound form of the PM-associated ARF6 although the
N-miristoyl of this latter protein is not cleaved in vivo. These data
support the notion that the specificity of IpaJ enzymatic activity
may come from its secretion site, where only a limited number of
its potential N-miristoylated substrates are accessible, rather than
from the specialization of its catalytic site to bind only a subset
of N-miristoylated proteins. It is noteworthy though that the
in vivo identification of IpaJ substrates was performed at 6 h post-
entry (Burnaevskiy et al., 2015). It would be interesting to check
if IpaJ is processing alternative N-miristoylated targets more
early during the infection process when both its distribution and
concentration should be very different, as one would hypothesize
based on our model.
Autophagy is the process that leads to capture, classically in a
double membrane compartment, and degradation of cytoplasmic
content in response to specific metabolic cues. ATG8/MAPLC3
(LC3) proteins are canonical marker of autophagosomes.
A subset of autophagy called xenoautophagy is used as a
countermeasure against foreign particles such as viruses and
bacteria (Baxt et al., 2013; Huang and Brumell, 2014). S.
flexneri had been previously shown to resist xenoautophagy
using its effectors IcsB and VirA (Ogawa et al., 2005; Dong
et al., 2012). Harnessing the power of the TSAR system to
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FIGURE 4 | Local vs. distant action of secreted effectors. Factors influencing the balance between local and distant action of effectors from their secretion site
inside host cells (A). Examples of local and distant action of effectors inside host cells. OspF is acting in the nucleus (distant action) to block the inflammatory
response, while IcsB and VirA were recently proposed to act directly on the cell-to-cell spread vacuole (local action) to favor bacterial escape in the cytoplasm.
Question marks indicate the possibility that OspF and IcsB/VirA could also have local and distant functions, respectively (B).
distinguish S. flexneri intracellular sub-populations (Campbell-
Valois et al., 2014b), we recently provided evidence that IcsB
and VirA are both acting in the vicinity of actively secreting
bacteria during cell-to-cell spread (Campbell-Valois et al., 2015).
IcsB, VirA, and LC3 relocated around secreting bacteria in
this context. A higher proportion of icsB and virA than wild
type bacteria were LC3 positive during cell-to-cell spreading.
icsB virA double mutant strain was even more attenuated than
the single mutants in a plaques formation assay, displaying
strongly diminished cell-to-cell spreading capacity. Moreover,
icsB virA mutated bacteria were trapped in LAMP2 positive
compartments from which they could hardly escape. These
results suggested that IcsB and VirA are acting in synergy to
allow escape from LC3 positive compartments formed during
cell-to-cell. LC3 is also recruited around secreting bacteria
during entry, but escape from the LC3 positive compartments
in this context seems to be relatively independent of IcsB
and VirA, although time of residence in the entry vacuole
might be slightly extended for icsB virA bacteria (Campbell-
Valois et al., 2015). Taking advantage of LC3 recruitment
during entry, we demonstrated that LC3-positive entry vacuoles
containing actively secreting bacteria were composed of a single
membrane, as in the process of LC3-associated phagocytosis
(LAP) previously reported in many bacterial pathogens (Lai
and Devenish, 2012; Huang and Brumell, 2014). Therefore, we
concluded that: (1) LC3 is recruited directly to existing bacteria-
containing vacuoles; (2) vacuolar bacteria concomitantly secrete
IcsB and VirA; (3) IcsB and VirA associate transiently with the
vacuolar membranes, (4) but they act locally to favor escape
from LC3-positive compartments most significantly during cell-
to-cell spread (Figure 4B). Observations that wild type bacteria
failed to complement in trans the deficiency of icsB virA bacteria
support this model (Campbell-Valois et al., 2015). The action
of IcsB and VirA in the vicinity of secreting bacteria is also
supported by evidence that icsB icsA, virA icsA, and icsB virA
icsA strains, which are all confined to the cytoplasm due to
cell-to-cell spread deficiency, did not significantly recruit LC3
(Campbell-Valois et al., 2015). Although IcsB and VirA are acting
in synergy, they have been shown to act on apparently unrelated
targets (Ogawa et al., 2005; Dong et al., 2012). VirA is a Rab
GTPase activating Protein (GAP) with Rab1-GTP being the most
efficiently catalyzed substrate, although other Rabs (e.g., Rab33
and Rab35) are also processed efficiently (approximately three-
fold less than Rab1) (Dong et al., 2012). The recruitment of Rab1
to bacteria containing vacuoles, phagosome, and autophagosome
(Ingmundson et al., 2007; Zoppino et al., 2010; Huang et al.,
2011; Campbell-Valois et al., 2012) suggests that Rab1 could be
recruited as well to vacuoles containing S. flexneri rendering
it available to neighboring VirA that would have been freshly
delivered through T3SA (Campbell-Valois et al., 2015). IcsB
has been suggested to protect S. flexneri from autophagy by
shielding IcsA from direct recognition by ATG5, a component
of the autophagy pathway (Ogawa et al., 2005). Other results
rather suggest that the role of IcsA in LC3 recruitment is
indirect through the formation of cell-to-cell spread vacuoles
that, as phagosome-like compartments, could be subject to LAP
(Campbell-Valois et al., 2015). This alternative model would
readily explain LC3 recruitment during entry, but its absence at
later stages of infection in icsA strains (Baxt and Goldberg, 2014;
Campbell-Valois et al., 2015). A cholesterol-binding domain was
also identified in IcsB and showed to be essential for the ability of
IcsB to enable autophagy escape (Kayath et al., 2010). Cholesterol
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 March 2016 | Volume 6 | Article 28
Campbell-Valois and Pontier Regulation of Shigella flexneri T3SA
being putatively found in abundance in the Golgi apparatus,
the PM and in compartments such as early phagosomes derived
from it (van Meer et al., 2008), freshly secreted IcsB could act
directly using its cholesterol binding domain on the membrane
of S. flexneri-containing vacuole. Interestingly, interruption of
cholesterol flux inside macrophages have been shown to block
fusion of phagosomes with lysosomes (Huynh et al., 2008). As yet,
there are still many unknowns concerning the targets and modes
of action of IcsB and VirA that enable escape from LC3-positive
vacuoles. In particular, how IcsB and VirA activities synergize in
that context is completely unknown.
An interesting example of how intrinsic properties of a given
effector could impact on its range of action was recently reported
for OspG. OspG is endowed with Ser/Thr kinase activity; it
binds specifically to E2 ubiquitin conjugating enzyme (e.g.,
UbCH5, UbCH7) loaded with ubiquitin (E2∼Ub) and blocks
IκBα degradation induced by tumor necrosis factor-α (TNFα,
Kim et al., 2005). It has also been shown to bind free ubiquitin
and polyubiquitin chains (Zhou et al., 2013), although E2∼Ub
seems to bind OspG with more affinity and increases its kinase
activity more readily than free ubiquitin (Grishin et al., 2014;
Pruneda et al., 2014). OspG is an atypical Ser/Thr kinase with a
shorter primary structure than its eukaryotic counterparts (Kim
et al., 2005; Grishin et al., 2014; Pruneda et al., 2014). Structures of
E2∼Ub-OspG complexes were recently reported (Grishin et al.,
2014; Pruneda et al., 2014). OspG is binding at the intersection of
the ubiquitin C-terminus and the catalytic site of the E2 to which
the latter is tethered, hence contacting both proteins constituting
the E2∼Ub complex. OspG adopts the active conformation of
Ser/Thr kinases (Grishin et al., 2014; Pruneda et al., 2014).
Both studies showed that disrupting interfaces between OspG
and E2∼Ub abrogated the capacity of OspG to decrease IkBα
degradation (Grishin et al., 2014; Pruneda et al., 2014). What is
particularly interesting for the main matter discussed here, is that
mutants in the primary structure of OspG disrupting its capacity
to interact with E2∼Ub have a much shorter half-life than the
wild type within host cells (Grishin et al., 2014). This observation
suggests that integration of OspG in a ternary complex with
E2∼Ub stabilizes its structure and/or protect it from proteases.
The range of action of OspG upon secretion is therefore likely
regulated by its binding affinity to E2∼Ub and the fraction of
OspG found in the complex with E2∼Ub at any given time.
Assuming that E2∼Ub concentration is relatively homogenous
across the cytoplasm, one can assume that the likelihood of
forming the tripartite complex will be maximal in the vicinity of
secreting bacteria where OspG concentration would be higher.
As OspG, either free or in the tripartite complex, diffuses away,
its effective concentration will decrease thereby mechanically
reducing the fraction found in the stabilizing tripartite complex.
In consequence, the concentration of free OspG will be higher
further down its diffusion gradient leading to reduced activity
and degradation. Therefore, this phenomenon will effectively
restrain OspG capacity to act at long distances. Nevertheless,
many aspects of the interplay between OspG, its kinase activity,
the E2∼Ub complex and the degradation of IκBα remain to be
understood.
Counterexamples: Effectors Acting at a
Long Distance from their Secretion Site
Shigella spp. possess 12 ipaH genes, but due to pseudogenes
and gene duplications they give rise to a maximum of 9 distinct
proteins across Shigella spp. (Bongrand et al., 2012). IpaHs are
E3 ubiquitin ligases (Rohde et al., 2007; Singer et al., 2008; Zhu
et al., 2008), and the search for their host targets has attracted
considerable interest (Rohde et al., 2007; Ashida et al., 2010,
2013, 2014; Wang et al., 2013; Suzuki et al., 2014; Tanner et al.,
2015). The substrates identified so far are molecules implicated
in inflammatory pathways converging on NFκb. Most of these
validated targets (e.g., NEMO, NFκB p65 etc.) are cytoplasmic
proteins that have not been reported in these studies to physically
associate or to relocate to S. flexneri-containing protrusions or
vacuoles where secretion is actively taking place (Campbell-
Valois et al., 2014b). The single exception might be glomulin,
which is degraded by the proteasome in an IpaH7.8-dependent
manner in macrophages (Suzuki et al., 2014). In this study,
glomulin was found in the vicinity of ipaH7.8 bacteria only. It is
not clear though if IpaH7.8 is ubiquitylating glomulin specifically
around secreting bacteria or away of bacteria, hence preventing
its recruitment to cytoplasmic bacteria. Since there have not been
many studies on glomulin reported in the literature, further work
will help shedding light on its role during bacterial infection.
OspF is arguably the prototypical example of effectors
acting at a long distance from their secretion site. Indeed,
OspF is a phosphothreonine lyase that specifically removes
the O-phosphate group from the threonine of the activation
loop of MAP kinases (i.e., Thr183 in Erk1) (Li et al., 2007).
This modification irreversibly inactivates the MAPK (e.g.,
ERK1/2, p38 etc.), blocks the activation of the interleukin-
8 promoter by the NFκb pathway and strongly dampens the
inflammatory response (Arbibe et al., 2007). These events
are taking place in the nucleus, where most phosphorylated
ERK1/2 are found. OspF also spontaneously locates to the
nucleus upon transfection of tissue culture cells (Arbibe et al.,
2007) (Figure 4B). OspF is sufficiently small (∼28 kDA)
to freely diffuse in the nucleus and it does not display a
typical basic nuclear localization sequence within its primary
structure. OspF could be anchored to the appropriate sites in
the nucleus through binding to Heterochromatin Protein 1 γ
(HP1γ) (Harouz et al., 2014), which is historically associated
with heterochromatin formation but has also been associated
with transcriptionally active loci such as the IL-8 promoter.
Supporting the important role of OspF in the nucleus, the
ospF mutant modulates the transcription of more genes than
other mutant strains tested including mxiE strain, which
lacks expression of second-wave effectors (Parsot, 2009). In
addition, affected genes are attributed to three distinct pathways:
inflammation, apoptosis and stress response, going way beyond
its classical role in dampening the inflammatory response
(Lippmann et al., 2015). OspB is another effector that is located
to the nucleus and that could be implicated in modulating the
inflammatory response, potentially coordinating its action with
OspF (Zurawski et al., 2009; Ambrosi et al., 2015). Nevertheless,
even in the case of effectors shown to be acting at a long
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distance, it is impossible to discard the possibility that they
have also a local function that has not been uncovered yet
(Figure 4B).
ARE T3SA IN OTHER BACTERIA ALSO
SPATIO-TEMPORALLY REGULATED?
Due to the “invade and evade” infectious strategy used by S.
flexneri (i.e., successive PM- and cytoplasm association), spatio-
temporal regulation of its T3SA is a plausible mode of action.
Since Burkholderia mallei and Burkhloderia pseudomallei have
also adopted a similar infectious strategy (Stevens et al., 2006;
Gong et al., 2011), their T3SA is probably regulated similarly to S.
flexneri. What about other type of T3SA-expressing pathogens?
Two main alternative infectious strategies exist: (i) bacteria
residing in vacuole, such as is the case with Salmonella spp. or
Chlamydia spp.; (ii) bacteria associating with the extracellular
face of the PM in a transient (Yersinia spp.) or stable fashion
(enteropathogenic E. coli and Citrobacter rodentium) (Figure 5).
Although they are considered paradigmatic vacuolar pathogens,
Salmonella spp. are not only found in large vacuoles and tighter
tubular compartments, but also in the cytoplasm (LaRock et al.,
2015; Liss and Hensel, 2015). These bacteria use T3SA encoded
by the Salmonella Pathogenicity Island-1 (SPI-1) to invade
epithelial cells. It was shown that acidification of the bacteria-
containing vacuole and ensuing sensing of neutral pH of the
cytoplasm through its translocon led successively to Salmonella
Pathogenicity Island-2 (SPI-2) T3SA assembly and activation
(Yu et al., 2010), which is important for shaping the vacuolar
niche of this pathogen (LaRock et al., 2015; Liss and Hensel,
2015). Nevertheless, whether bacteria that are located in the
middle of large vacuoles and in which the T3SA is not directly
contacting the host membrane are actively secreting or not
is currently unknown. As infection progresses, the evolution
of these vacuoles into tight tubular compartments (LaRock
et al., 2015; Liss and Hensel, 2015) might allow membrane-
bound Salmonella to maintain lasting SPI-2 T3SA activities.
Another possible opportunity for inactivation of SPI-1 and SPI-
2 T3SA could happen in cytoplasmic bacteria, which represent
between 6 and 51% of intracellular bacteria depending on
the stage of infection (Knodler et al., 2014). Enteropathogenic
E. coli (EPEC) and C. rodentium associate stably with the
PM through the formation of pedestals structure by secreting
their own receptor Tir (Kenny et al., 1997; Mundy et al.,
2005). As yet, methods developed to measure secretion activity
have not shown regulation of T3SA activity following initial
activation (Charpentier and Oswald, 2004; Mills et al., 2008,
2013; Yerushalmi et al., 2014). The different stages of adhesion
in EPEC (e.g., bundling forming pili-, T3SS/Tir-, and EspA-
dependent), leading progressively to more intimate interactions
between bacteria and the host PM might nonetheless represent
circumstances where the T3SA activity would be modulated
(Cleary et al., 2004). Studies about T3SA regulation mechanisms
in these bacterial pathogens and others would certainly benefit
from the development of secretion activity reporters as well
(Campbell-Valois and Sansonetti, 2014).
FIGURE 5 | Alternative lifestyles of pathogenic bacteria associated
with host cells and potential mechanisms of regulation of their T3SA.
Salmonella invade epithelial cells using Salmonella Pathogenicity Island-1
(SPI-1) T3SA (ia). pH change in the vacuole and concomitant sensing of
cytosolic pH induce activation of Salmonella Pathogenicity Island-2 (SPI-2)
T3SA in Salmonella (ib). As bacteria accumulate in vacuole, they are not in
contact with the membrane, which would probably inactivate SPI-1 and SPI-2
T3SA (ib). Occasionally Wt Salmonella escape their vacuole and access the
cytoplasm. Loss of contact with vacuolar membrane in this case could also
potentially lead to T3SA inactivation (ic). EPEC adhesion to the PM of epithelial
cells proceeds in multiple stages (e.g., bundling forming pili-, T3SS/Tir- and
EspA-dependent, etc.), culminating in the formation of actin-rich pedestals
structure at bacterial adhesion point. Throughout this adhesion process,
activity of the T3SA could be modulated (iia,b). In addition, within
microcolonies some bacteria will occasionally loose contact with the PM,
which similarly to the previous example could inactivate T3SA. Secreting
bacteria, green; non-secreting bacteria, gray.
CONCLUSIONS
Many studies discussed above addressed how the regulated
secretion of bacterial effectors impacts on their subcellular
distribution, concentration, and function. Such observations
could have important consequences. For example, part of
effectors specificity could stem from their location rather than
from the evolution of their catalytic site to accommodate a
more restrained group of substrates. Historically, experimental
approaches employed to determine host protein targets of
bacterial effectors have been relying mostly on yeast-two-hybrid
screens and overexpression in tissue culture cells. Although
the legacy of these approaches in host-pathogen interactions
is considerable, they are not optimal to find host targets that
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 March 2016 | Volume 6 | Article 28
Campbell-Valois and Pontier Regulation of Shigella flexneri T3SA
are selected on the basis of their location at or around actively
secreting bacteria. Novel experimental strategies will have to be
developed to tackle these questions.
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